FDA Regulation of Stem Cell Therapies: Using a Stem Cell Fraud Strike Force to Separate Fact from Fi...
FDA Regulation of Stem Cell Therapies: Using a Stem Cell Fraud Strike Force to Separate Fact from Fiction
About this item
Full title
Author / Creator
Publisher
Food and Drug Law Institute (FDLI)
Journal title
Language
English
Formats
Publication information
Publisher
Food and Drug Law Institute (FDLI)
Subjects
More information
Scope and Contents
Contents
In recent years, growth in the U.S. stem cell industry has surged through online marketing of unproven cell therapies to treat everything from multiple sclerosis and dementia to autism. This Article focuses most closely on adipose (fat) derived stem cell therapies because of their prevalence in the market and the U.S. Food and Drug Administration’s...
Alternative Titles
Full title
FDA Regulation of Stem Cell Therapies: Using a Stem Cell Fraud Strike Force to Separate Fact from Fiction
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_gale_incontextgauss__A649165570
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_incontextgauss__A649165570
Other Identifiers
ISSN
1064-590X
